Two Chemotherapy Regimens Plus or Minus Bevacizumab
Clinical trial NCT03351296 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03351296
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-26
- Primary completion
- 2028-12-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.